<DOC>
	<DOCNO>NCT00463112</DOCNO>
	<brief_summary>Studies effect sibutramine , anti-obesity drug , hormonal metabolic feature woman polycystic ovary syndrome ( PCOS ) lacking . The objective study examine effect sibutramine plus hypocaloric diet body composition , hormonal metabolic parameter insulin resistance obese patient PCOS . Overweight obese woman PCOS place hypocaloric diet plus sibutramine ( 10 mg/day ) first month hypocaloric diet plus sibutramine ( 10 mg/day ) hypocaloric diet subsequent 6 month . The main outcome measure : Body composition , hormonal metabolic feature insulin sensitivity ( OGTT ) baseline , 3 6 month treatment .</brief_summary>
	<brief_title>Effect Diet Plus Sibutramine Hormonal Metabolic Features Overweight Obese Women With PCOS</brief_title>
	<detailed_description>The Polycystic Ovary Syndrome ( PCOS ) one common hormonal disorder woman reproductive age . As syndrome multiple component , reproductive ( chronic anovulation infertility ) , metabolic cardiovascular . Although lean woman present PCOS , obesity one main manifestation syndrome . Androgen excess insulin resistance underline much clinical metabolic feature syndrome . Recent evidence suggest PCOS patient substantial risk development metabolic cardiovascular abnormality similar present metabolic syndrome . Obesity , particularly abdominal type , present approximately half woman PCOS , although several study show percentage vary 30 % 75 % . Several study demonstrate obesity woman PCOS enhance clinical metabolic abnormality syndrome , since obese woman PCOS profound insulin resistance type 2 DM , dyslipidemia cardiovascular disease ’ risk , great level androgen due low SHBG level . A modest weight loss ( &lt; 5 % even 5-10 % initial body weight ) show improve ovulation frequency conception , reduce miscarriage , hyperlipidemia , hypertension , hyperglycemia insulin resistance woman PCOS . There study effect anti-obesity drug administration obese overweight woman PCOS . To author ’ best knowledge , effect sibutramine , serotonin noradrenaline reuptake inhibitor ( SNRI ) approve antiobesity drug , study one study obese woman PCOS . Given lack information , aim present study investigate additional effect sibutramine combine hypocaloric diet body composition , hormonal lipid parameter insulin resistance obese woman PCOS . Study 's design The study prospective , open label , randomize , comparative trial . The study design include 3 period ; screen period order confirm diagnosis PCOS , lead-in period ( 4 week duration ) patient prescribe 10mg/day sibutramine plus 600 kcal deficient diet , treatment period ( subsequent 6 month ) subject randomized 2:1 ratio S group ( 10 mg/day Sibutramine plus hypocaloric diet ) D group ( hypocaloric diet ) . Diet base individualized basal metabolic rate define Harris-Benedict ’ equation adjust moderate physical activity . Before enter lead-in period subject prescribe energy-restricted diet contain 50 % carbohydrate , 30 % fat ( 10 % saturate ) , 20 % protein . After randomization , subject advise modify eating habit throughout study period . The randomization perform use seal envelope prepare advance study research associate involve study . A randomisation table create use block 3 number possible combination . A random number generator used create balance treatment group . Clinical measure Body weight , waist circumference fast blood sample total testosterone ( T ) , Sex Hormone Binding Globulin ( SHBG ) , dehydroepiandrosterone sulfate ( DHEAS ) , androstenedione ( Δ4Α ) , 17a-hydroxyprogesterone , follicle stimulate hormone ( FSH ) , luteinising hormone ( LH ) , thyroid stimulate hormone ( TSH ) , total cholesterol ( TC ) , triglyceride ( TG ) , low-density lipoprotein cholesterol ( LDL-C ) , high-density lipoprotein cholesterol ( HDL-C ) , glucose , insulin take baseline well 3 6 month treatment . At period , Oral Glucose Tolerance Test ( OGGT ) 75-g glucose perform . Blood sample collect 08:30 09:00 a.m. , overnight fast , follicular phase woman ’ menstrual cycle . Monthly , subject ’ body weight measure , adverse event , heart rate , blood pressure , study drug compliance determine pregnancy urine test perform . Body weight always determine morning hour subject light clothes .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Sibutramine</mesh_term>
	<criteria>overweight obese woman PCOS Nonclassical 21hydroxylase deficiency , hyperprolactinemia , adrenal ovarian tumor Cushing ’ disease , hypertension , thyroid dysfunction , overt diabetes mellitus concomitant treatment antihypertensive drug , SSRI SNRI drug , oral contraceptive pill antiandrogen treatment ( cyproterone acetate , spirolactone , LHRH agonist ) insulin sensitize agent ( metformin , pioglitazone , roziglitazone ) may interact insulin sensitivity lipid profile .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Polycystic Ovary Syndrome</keyword>
	<keyword>weight loss</keyword>
	<keyword>Hyperadrogonemia</keyword>
	<keyword>Sibutramine</keyword>
</DOC>